+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

IIT Ropar develops ventilation support for COVID-19 patients

Jul 6, 2020, 17:49 IST
PTI
Chandigarh, Jul 6 () The researchers at the Indian Institute of Technology, Ropar have developed a compact and affordable ventilation support for the less critical COVID-19 patients, a statement said on Monday.

The design of the a Bilevel Positive Airway Pressure (BiPAP) machine is such that it is easy to operate and can be assembled with ease in remote areas, villages or at home, it said.

Advertisement

BiPAP is a mode of ventilation which maintains positive pressure for air intake and a low pressure for expiration, the statement said.

The machine is made of readily available electronic and mechanical parts and a single unit can support multiple patients, provided the airflow is sufficient, it said.

It can be used for the less critical cases where patients do not require intubation by specialized staff, the statement by the institute said.

Neha Sardana, from the department of Metallurgical and Materials Engineering of IIT Ropar, along with Gaurav Pal Singh, a research scholar, developed the ventilation support, it said.

Advertisement

The mass production of the machine would cost around Rs 6,500 per unit, the statement said.

"The COVID-19 pandemic has presented a massive challenge to healthcare services around the globe which requires innovative and immediate solutions. This BiPAP machine in the current situation aims to deliver an economical and user-friendly respiratory support for non-critical patients and a backup resource for hospitals facing ventilation shortage," the institute said. CHS VSD AD

(This story has not been edited by www.businessinsider.in and is auto–generated from a syndicated feed we subscribe to.)
You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article